ZWZi-Long Wang

Zi-Long Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zi-Long Wang has a total of 132 co-authors. Here are the top co-authors by number of shared publications:

  • Min Ye

    Peking University

    22 shared publications
  • Meng Zhang

    State Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing China

    9 shared publications
  • Xue Qiao

    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China

    8 shared publications
  • Hao-Tian Wang

    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China

    5 shared publications
  • Hao-Tian Wang

    State Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing China

    5 shared publications
  • Hai-Dong Wang

    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China

    4 shared publications

Latest Publications

  • Open Access

    Gap-free near-T2T genome assembly of Digitalis lanata enables complete enzymatic production of digoxigenin

    by Min Ye, Hao-Tian Wang, Yu-Xun Zhu, Fanjing Yang, Yi Chen, Chuyu Ye, Zi-Long Wang, Yong Zhao

    Digoxigenin is the aglycone precursor of digoxin, a clinically important cardiotonic drug whose steroid scaffold is substituted with C12 β and C14 β hydroxyl groups and bears a characteristic C17 butenolide ring. Despite its longstanding clinical importance, the biosynthetic pathway leading to digoxigenin has remained largely unresolved. Here, we report the first gap-free near-telomere-to-telomere genome assembly of Digitalis lanata and construct an engineered enzymatic cascade for digoxigenin synthesis. Through comparative genomics, biosynthetic gene cluster analysis, transcriptome co-expression analysis, and biochemical characterization, we uncovered a suite of enzymes, including cytochrome P450s, β -hydroxysteroid dehydrogenases, progesterone 5 β -reductases, 2-oxoglutarate-dependent dioxygenases, and a BAHD acyltransferase, which collectively reconstitute the biosynthesis of digitoxigenin from cholesterol in vitro . We further identified Dl 2ODD3 as the previously elusive steroid 12 β -hydroxylase. While the native enzyme lacked detectable activity toward digitoxigenin, its crystal structure enabled rational engineering of a variant capable of hydroxylating digitoxigenin, thereby completing the enzymatic biosynthesis of digoxigenin. Together, these findings establish the complete biosynthetic framework for cardenolides and provide a foundation for sustainable biomanufacturing of this important class of medicinal natural products.

  • Combinatorial Biosynthesis of Antithrombotic Flavonoid 6‐ O ‐Glycosides From Carthamus tinctorius

    by Zi‐Long Wang, Guo Ye, Meng Zhang, Yun‐Gang Tian, Hao‐Tian Wang, Jian Huang, Xiao‐Dong Luo, Min Ye

    Flavonoid 6‐ O ‐glycosides from Carthamus tinctorius (safflower) represent a unique class of potential antithrombotic agents. However, their pharmaceutical development has been hindered by limited natural resources. In this study, we characterized four key biosynthetic enzymes from C. tinctorius : Ct6OGT (6‐ O ‐glycosyltransferase), Ct7OGT (7‐ O ‐glycosyltransferase), Ct3OGT (3‐ O ‐glycosyltransferase), and CtFLS (flavonol synthase). Among them, Ct6OGT is the first identified high‐regioselectivity flavonoid 6‐ O ‐glycosyltransferase. By combining these enzymes with upstream genes identified from safflower, we established an in vitro enzymatic approach for the synthesis of 6‐hydroxykaempferol 3,6,7‐tri‐ O ‐glycosides. Notably, enzymatic assays demonstrated that the 3,6,7‐ O ‐triglycosides were synthesized via a sequential linear glycosylation pathway, in the order of 6‐ O ‐, 7‐ O ‐, and finally 3‐ O ‐glycosylation. Through combinatorial biosynthesis, we further produced 26 flavonoid 6‐ O ‐glycosides, including naturally occurring compounds from C. tinctorius and novel analogs. Subsequent evaluation in a zebrafish model revealed these flavonoid 6‐ O ‐glycosides exhibited antithrombotic activities, with 6‐hydroxylation and 6‐ O ‐glycosylation remarkably enhancing the potency. This work represents the first report of an enzymatic synthetic method for flavonoid 6‐ O ‐glycosides, and provides a valuable foundation for their future drug development.

  • Combinatorial Biosynthesis of Antithrombotic Flavonoid 6‐ O ‐Glycosides From Carthamus tinctorius

    by Zi‐Long Wang, Guo Ye, Meng Zhang, Yun‐Gang Tian, Hao‐Tian Wang, Jian Huang, Xiao‐Dong Luo, Min Ye

    Flavonoid 6‐ O ‐glycosides from Carthamus tinctorius (safflower) represent a unique class of potential antithrombotic agents. However, their pharmaceutical development has been hindered by limited natural resources. In this study, we characterized four key biosynthetic enzymes from C. tinctorius : Ct6OGT (6‐ O ‐glycosyltransferase), Ct7OGT (7‐ O ‐glycosyltransferase), Ct3OGT (3‐ O ‐glycosyltransferase), and CtFLS (flavonol synthase). Among them, Ct6OGT is the first identified high‐regioselectivity flavonoid 6‐ O ‐glycosyltransferase. By combining these enzymes with upstream genes identified from safflower, we established an in vitro enzymatic approach for the synthesis of 6‐hydroxykaempferol 3,6,7‐tri‐ O ‐glycosides. Notably, enzymatic assays demonstrated that the 3,6,7‐ O ‐triglycosides were synthesized via a sequential linear glycosylation pathway, in the order of 6‐ O ‐, 7‐ O ‐, and finally 3‐ O ‐glycosylation. Through combinatorial biosynthesis, we further produced 26 flavonoid 6‐ O ‐glycosides, including naturally occurring compounds from C. tinctorius and novel analogs. Subsequent evaluation in a zebrafish model revealed these flavonoid 6‐ O ‐glycosides exhibited antithrombotic activities, with 6‐hydroxylation and 6‐ O ‐glycosylation remarkably enhancing the potency. This work represents the first report of an enzymatic synthetic method for flavonoid 6‐ O ‐glycosides, and provides a valuable foundation for their future drug development.

  • Discovery and Engineering of Prenyltransferases in Glycyrrhiza inflata Enable Diversified Biosynthesis of Prenylated Flavonoids

    by Lei Ye, Zi-Qi Xu, Yun-Gang Tian, Jia Xu, Yan-Fang Yang, Zi-Long Wang, Min Ye

    Prenylated flavonoids represent a significant class of bioactive natural products widely distributed in plants, and prenyltransferases (PTs) play a key role in their biosynthesis. Although a number of flavonoid prenyltransferases have been reported, they generally exhibit narrow substrate promiscuity, low catalytic efficiency, and limited modification sites (primarily at C6 or C8 of the A-ring). Herein, six flavonoid prenyltransferases were identified from Glycyrrhiza inflata, which can be classified into two groups based on their regioselectivity. GinPT1, GinPT2, and GinPT5 catalyze C6 prenylation of flavonoid substrates, whereas GinPT3, GinPT4, and GinPT6 catalyze C3′ prenylation. Through rational design, a single-site mutation M171I was found to enhance both the substrate promiscuity and catalytic efficiency of GinPT5. This mutant is capable of prenylating over 30 phenolic compounds, with the highest conversion rate reaching 98%. GinPT5-M171I represents the plant PT with the broadest substrate promiscuity reported to date. Furthermore, residue #171 may be a general key amino acid that determines the substrate selectivity of plant PTs. Using the above native and engineered enzymes, a biosynthesis platform was established that can produce a variety of prenylated phenolic compounds with promising pharmacological activities.


  • Functional characterization of plant UGT93s producing prenylated phenolic glycosides

    by Hong‐Ye Li, Jian‐Lin Zou, Bao Nie, Zi‐Long Wang, Meng Zhang, Chun‐Xue Zhao, Yan‐Fang Yang, Xi‐Ran Zhang, Xin‐Yue Zhan, Li Wang, et al.

    Prenylated phenolic glycosides, such as nodakenin, represent a class of natural products with diverse bioactivities. Their metabolic engineering production remains largely unexplored, primarily due to the scarcity of efficient UDP‐glycosyltransferases (UGTs) capable of catalyzing prenylated phenolic substrates. In this study, we characterized several UGT93 enzymes from Angelica decursiva that catalyzed the glycosylation of nodakenetin. Enzymatic assays revealed a pronounced catalytic preference of these enzymes toward various types of prenylated phenolic substrates. Notably, this substrate preference is conserved across UGT93s from other species and a reconstructed ancestral enzyme. Structural analysis and mutation experiments revealed that the preference was caused by the substrate binding with several hydrophobic and aromatic residues. This study highlights the biocatalytic potential of the UGT93 family enzymes, offering promising biocatalysts for the glycosylation of plant‐derived prenylated phenolics.


  • Elucidating the Biosynthetic Pathway and Mechanisms of Retrochalcones

    by Lei Ye, Zi-Long Wang, Zi-Qi Xu, Yun-Gang Tian, Meng Zhang, Ikuro Abe, Min Ye

    Chalcone is a privileged natural product skeleton for drug discovery, and retrochalcone represents a group of nonclassical chalcones with a distinctive oxygen substitution pattern. Echinatin, a hepatoprotective agent, is a retrochalcone derived from Glycyrrhiza inflata. Despite their initial discovery half a century ago, the biosynthetic mechanisms of retrochalcones have remained elusive. In this work, we identified a ketoreductase, GinKR1, which selectively catalyzes the reduction of the 1″-carbonyl group of the dibenzoylmethane precursor 2'-O-methyllicodione, followed by spontaneous dehydration to form the retrochalcone skeleton. Our findings reveal that the A and B rings of retrochalcones are derived from the shikimate and polyketide pathways, respectively, which are reversed to normal chalcones. In addition, 18O isotope labeling verifies that the carbonyl oxygen of retrochalcones is derived from the hydroxyl group introduced by a flavanone 2-hydroxylase. The complete biosynthetic pathway of echinatin was elucidated by identifying six enzymes from G. inflata. Moreover, we determined the crystal structure of GinKR1 and identified a critical α10 helix responsible for its regioselectivity. With this α10 helix as a marker, we further discovered homologous genes of GinKR1 from 185 plant species. This study elucidates the biosynthetic pathway and underlying mechanisms of retrochalcones.


  • Insights into the Mechanisms of Sugar Acceptor Selectivity of Plant Flavonoid Apiosyltransferases

    by Hao-Tian Wang, Zi-Long Wang, Nian-Hang Chen, Wei Huang, Jian-Lin Zou, Yun-Gang Tian, Guo Ye, Jian Huang, Ruibo Wu, Min Ye

    Flavonoid apiosides are widely distributed in cereals, fruits, vegetables, and medicinal herbs and play critical roles in human health. Their facile and efficient synthesis has been a hot but challenging topic in the fields of both organic chemistry and biosynthesis. However, very few apiosyltransferases (ApiGTs) have been reported thus far. Here, we report the first flavonoid apiosyltransferase (CaApiGT) capable of catalyzing the 2″-O-apiosylation of flavonoid 3-O-glycosides in chickpea (Cicer arietinum). Moreover, we identify PcApiGT from parsley (Petroselinum crispum), which catalyzes the 2″-O-apiosylation of flavonoid 7-/4'-O-glycosides. To dissect the mechanisms underlying their different sugar acceptor selectivity, we obtain 10 complex crystal structures of CaApiGT and PcApiGT with resolutions ranging from 1.55 to 2.65 Å, including CaApiGT/UDP, 6 ternary structures of CaApiGT/UDP/sugar acceptors, PcApiGT/UDP, and 2 ternary structures of PcApiGT/UDP/sugar acceptors. Structural analyses, theoretical calculations, and site-directed mutagenesis indicate that flavonoid 3-O-glycosides and 7-O-glycosides exhibit a T-shape and streamline shape, respectively, and fit the active pockets of CaApiGT and PcApiGT. Moreover, the sugar acceptor selectivity of these two apiosyltransferases is determined by a key α-helix. In CaApiGT, this α-helix contains multiple polar amino acids, particularly a threonine residue at its end. Using this α-helix motif as a marker, we further characterize four apiosyltransferases from Leguminosae plants that exhibit functional similarity to CaApiGT. This work unravels detailed sugar acceptor selectivity mechanisms of plant apiosyltransferases and provides efficient biocatalysts for the synthesis of flavonoid apiosides.


  • Top Cited Papers
    Open Access

    Elucidation of the biosynthetic pathway of hydroxysafflor yellow A

    by Zi-Long Wang, Hao-Tian Wang, Guowei Chang, Guo Ye, Meng Zhang, Jiang Chen, Min Ye

    Hydroxysafflor yellow A (HSYA) is a clinical investigational new drug for the treatment of acute ischemic stroke. It has a unique quinochalcone di-C-glycoside structure and is exclusively found in the flowers of safflower (Carthamus tinctorius). To date, little is known about the biosynthesis of HSYA. In this work, we characterize four key biosynthetic enzymes from C. tinctorius: CtF6H (6-hydroxylation of naringenin to produce carthamidin), CtCHI1 (isomerization between carthamidin and isocarthamidin), CtCGT (flavonoid di-C-glycosyltransferase), and Ct2OGD1 (2-oxoglutarate-dependent dioxygenase). Notably, Ct2OGD1 coordinates with CtCGT to convert carthamidin or isocarthamidin to HSYA. Functions of these genes are confirmed by VIGS (virus-induced gene silencing) in C. tinctorius, de novo biosynthesis of HSYA in Nicotiana benthamiana, semi-synthesis in yeast, and in vitro enzyme assays. We further find that the simultaneous presence and high expression of the above four key genes, together with the absence of F2H (flavanone 2-hydroxylase) genes, are essential for the biosynthesis of HSYA, and thus interpret mechanisms for the unique presence of HSYA in safflower. This work elucidates the biosynthetic pathway of HSYA and provides a foundation for the green and efficient production of this valuable medicinal natural product.


  • Molecular and Structural Characterization of a Chalcone di-C-Methyltransferase RdCMT from Rhododendron dauricum and Its Application in De Novo Biosynthesis of Farrerol in Pichia pastoris

    by Meng Zhang, Yang-Oujie Bao, Zonglin Dai, Zhilan Qian, Haishuang Yu, Jia-Jing Zhou, Yi Chen, Zilong Wang, Kaituo Wang, Menghao Cai, et al.

    Methylation plays a crucial role in drug design and optimization. While numerous methyltransferases have been characterized from plants, C-methyltransferases, particularly those targeting phenolic skeletons, are rare. In this study, we identified a novel di-C-methyltransferase RdCMT from the medicinal plant Rhododendron dauricum. RdCMT catalyzes a sequential two-step 3'-C/5'-C-methylation of naringenin chalcone, leading to the biosynthesis of farrerol. RdCMT exhibited a strict substrate specificity for chalcones. Through combinatorial catalysis, a series of C-methylated flavonoids were synthesized. Moreover, farrerol was synthesized de novo in Nicotiana benthamiana and Pichia pastoris with yields of 0.4 mg/g (dry weight) and 149.0 mg/L, respectively. The structure of RdCMT was determined using cryo-electron microscopy (cryo-EM), revealing that residues R328 and G296 significantly influence the substrate specificity of RdCMT. This work not only introduces a potent biocatalyst for the preparation of C-methylated flavonoids but also offers insights into the catalytic mechanisms of C-methyltransferases.


  • Open Access

    Complete biosynthetic pathway of furochromones in Saposhnikovia divaricata and its evolutionary mechanism in Apiaceae plants

    by Jian-Lin Zou, Hong-Ye Li, Bao Nie, Zi-Long Wang, Chun-Xue Zhao, Yun-Gang Tian, Li-Qun Lin, Wei-Zhe Xu, Zhuang-Wei Hou, Wen-Kai Sun, et al.

    Furochromones are specific bioactive secondary metabolites of many Apiaceae plants. Their biosynthesis remains largely unexplored. In this work, we dissect the complete biosynthetic pathway of major furochromones in the medicinal plant Saposhnikovia divaricata by characterizing prenyltransferase, peucenin cyclase, methyltransferase, hydroxylase, and glycosyltransferases. De novo biosynthesis of prim-O-glucosylcimifugin and 5-O-methylvisamminoside is realized in Nicotiana benthamiana leaves. Through comparative genomic and transcriptomic analyses, we further find that proximal duplication and high expression of a pentaketide chromone synthase gene SdPCS, together with the presence of a lineage-specific peucenin cyclase gene SdPC, lead to the predominant accumulation of furochromones in the roots of S. divaricata among surveyed Apiaceae plants. This study paves the way for metabolic engineering production of furochromones, and sheds light into evolutionary mechanisms of furochromone biosynthesis among Apiaceae plants.